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Introduction: Reflex laboratory screening of blood samples
with CD4 counts of less than 100 cells/ml for cryptococcal
antigen (CrAg) is being introduced nationally in South Africa.
This enables identification of patients with sub-clinical
cryptococcal infection and administration of pre-emptive
fluconazole therapy to prevent life-threatening meningitis.
However, access to laboratories may be limited in rural areas.
The CrAg lateral flow assay (LFA) is ideally formatted for
point-of-care (POC) use. Therefore, the accuracy of the CrAg
LFA on finger-prick blood and urine samples performed in
clinic settings by front-line health workers was determined.
Methods: Patients with asymptomatic cryptococcal antige-
naemia detected by reflex laboratory-based CrAg screening
were identified from HIV clinics in Johannesburg, along with
CrAg-negative controls. A CrAg LFA was performed on finger-
prick blood and urine samples by a nurse and repeated in a
laboratory. Results of POC and laboratory-performed LFA
tests were compared to the reference laboratory-based CrAg
LFA test performed on plasma during the previous month.
Testing was repeated on positive urine samples following
centrifugation at 2000 rpm for 10 minutes.
Results: Fifty-three patients with known CrAg status (19
CrAg-positive: 34 CrAG-negative) were tested using POC and
laboratory-based CrAg LFA. POC CrAg LFA on blood had a
sensitivity of 89.5% (95% CI: 66.798.7%) and specificity of
100% (95% CI: 89.7100%). Both CrAg positive patients who
were tested as POC-LFA negative had very low CrAg titres.
Sensitivity improved to 100% using laboratory-based testing.
POC CrAg LFA on urine had a sensitivity of 84.2% (95% CI:
60.4296.62%) and a specificity of 44.1% (95% CI: 27.2
62.1%), with no improvement using laboratory-based testing,
or after centrifugation.
Conclusions: CrAg LFA on finger-prick blood is an appropriate
POC method for screening HIV-infected adults commencing
ART. This could reduce turn-around time and loss to follow
up, particularly where laboratory access is limited. Urine
samples should not be used due to a high rate of false
positive results.
Abstract THPDB0201Table 1. Sensitivity and specificity of the CrAg LFA used on blood/urine at the POC and in a laboratory,
compared to laboratory LFA on plasma
n, (Sensitivity, 95% CI) n, (Specificity, 95% CI)
POC finger-prick blood 17/19 (89.47%, 66.8698.7%) 34/34 (100%, 89.72%100%)
Lab pipetted blood 19/19 (100%, 82.35100%) 34/34 (100%, 89.72100%)
POC dipped urine 16/19 (84.2%, 60.496.6%) 19/34 (44.1%, 27.262.1%)
Lab pipetted urine 15/19 (79.0%, 54.494.0%) 17/34 (50.0%, 32.467.6%)
Lab centrifuged urine N/A 10/18 (55.6%, 30.778.5%)
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